Avian Flu Collaborations: Aventis, Chiron To Produce Vaccine For NIH Clinical Trials

Each company will manufacture 8,000 doses of the avian strain under contracts with the National Institutes of Health. Aventis will perform stability testing to see if its vaccine is suitable for stockpiling.